Ainos, Inc.
NASDAQ: AIMDW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Chun-Hsien Tsai
- Employees
- 44
- Headquarters
- San Diego, United States
- IPO year
- 2021
- Market cap
- $10.1M
- Website
- https://www.ainos.com
Loading AIMDW…
Loading profile data…Frequently asked questions about AIMDW
What does Ainos, Inc. (AIMDW) do?
Ainos, Inc. operates as a healthcare enterprise dedicated to advancing medical technologies. Its core focus involves developing both point-of-care diagnostic solutions and innovative, safe therapeutic options for various health conditions. The company's offerings include a COVID-19 antigen rapid test kit. This is complemented by the Ainos' cloud...
Where does AIMDW trade?
Ainos, Inc. (AIMDW) trades on the NASDAQ Global Market.
What sector is AIMDW in?
Ainos, Inc. (AIMDW) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Ainos, Inc.?
Chun-Hsien Tsai is the chief executive officer of Ainos, Inc. (AIMDW).
Where is Ainos, Inc. headquartered?
Ainos, Inc. is headquartered in United States.
Does AIMDW pay a dividend?
Ainos, Inc. (AIMDW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AIMDW go public?
Ainos, Inc. (AIMDW) completed its initial public offering in 2021.